Edmond Mok
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Edmond Mok
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Edmond Mok
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO General Counsel | |
Cardiac Pathways Corp.
 Cardiac Pathways Corp. Medical SpecialtiesHealth Technology Cardiac Pathways Corp. designs, develops and manufactures cardiac diagnosis systems. Its products consist principally of systems for performing ablation treatment and for diagnostic mapping. Cardiac Pathways is located in Sunnyvale, CA. | Medical Specialties | Sales & Marketing | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| HUMANIGEN, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | ||
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| REVANCE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| Purdue University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Graduate Degree | |
Lawrence Berkeley National Laboratory
 Lawrence Berkeley National Laboratory Miscellaneous Commercial ServicesCommercial Services Lawrence Berkeley National Laboratory engages on research of environmental studies, nanoscience, and quantitative biology, physics and nuclear energy. The lab is funded by the U.S. Department of Energy and managed by the University of California. It was founded in 1931 by Ernest Orlando Lawrence and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Sofinnova Management VI LLC | Corporate Officer/Principal | ||
| Sofinnova Management VII LLC | Corporate Officer/Principal | ||
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
| NATERA, INC. | Medical Specialties | Director/Board Member | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member | |
| NUCANA PLC | Biotechnology | Director/Board Member | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University School of Medicine | College/University | Doctorate Degree | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| Y-MABS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Financial Conglomerates | Director/Board Member | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Chairman | |
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sofinnova Investments, Inc. (Investment Management)
 Sofinnova Investments, Inc. (Investment Management) Investment ManagersFinance Sofinnova Investments, Inc. (Investment Management) (Sofinnova-IM) is the investment management division of Sofinnova Investments, Inc., a venture capital firm headquartered in Menlo Park, California. Founded in 1974, Sofinnova-IM serves as an investment adviser to pooled investment vehicles and separately managed accounts. | Investment Managers | Chief Executive Officer | |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 41 |
| Schweiz | 5 |
| Irland | 4 |
| Australien | 2 |
| Belgien | 2 |
Sektoral
| Health Technology | 36 |
| Consumer Services | 6 |
| Commercial Services | 4 |
| Finance | 3 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 133 |
| Corporate Officer/Principal | 39 |
| Independent Dir/Board Member | 35 |
| Chairman | 24 |
| Chief Executive Officer | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Healy | 50 |
| Daniel Janney | 47 |
| Howard Rosen | 26 |
| Robert Chess | 22 |
| Donald Santel | 20 |
| Bradford Goodwin | 15 |
| Robert S. Michitarian | 12 |
| Curtis L. Ruegg | 11 |
| Abhay Joshi | 10 |
| Henk Kocken | 10 |
| Henry H. Hsu | 7 |
- Börse
- Insiders
- Edmond Mok
- Unternehmensverbindungen
